国药控股(01099.HK) 公布截至今年3月底止首季度业绩，按中国公认会计原则，营业总收入1,416.62亿元人民币(下同)，按年跌3.8%；归属于母公司所有者净利润14.57亿元，按年升2.6%；每股盈利0.47元。(js/w)
| 公布日期 | 派息事项 | 派息内容 |
|---|---|---|
| 2025/03/24 | 末期业绩 | 股息：人民币 0.6800 |
| 2024/10/28 | 第三季业绩 | 无派息 |
| 2024/08/26 | 中期业绩 | 无派息 |
| 2024/04/29 | 第一季业绩 | 无派息 |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.